miRNAs in non-alcoholic fatty liver disease

被引:28
|
作者
He, Zhen [1 ]
Hu, Cheng [1 ]
Jia, Weiping [1 ]
机构
[1] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai Diabet Inst,Shanghai Clin Ctr Diabet, Shanghai 200233, Peoples R China
基金
中国国家自然科学基金;
关键词
nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; hepatocellular carcinoma; miRNA; HEPATIC LIPID-ACCUMULATION; DOWN-REGULATION; CIRCULATING MICRORNAS; LIPOPROTEIN-LIPASE; CHOLINE-DEFICIENT; UP-REGULATION; MOUSE MODEL; EXPRESSION; INHIBITION; METABOLISM;
D O I
10.1007/s11684-016-0468-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver cirrhosis and hepatocellular carcinoma and is a considerable threat to public health. miRNAs are important post-transcriptional regulators of gene expression, and the dysregulation of miRNAs is involved in various biological processes in the liver, including lipid homeostasis, inflammation, apoptosis, and cell proliferation. Recently, a number of studies have described the association between miRNAs and NAFLD progression and have shown that circulating miRNAs reflect histological changes in the liver. Therefore, circulating miRNAs have potential use for the evaluation of NAFLD severity. In this review, we discuss the involvement of miRNAs in NAFLD pathogenesis and the key role of miRNAs in the screening, diagnosis, and staging of NAFLD.
引用
收藏
页码:389 / 396
页数:8
相关论文
共 50 条
  • [41] Pathology of non-alcoholic fatty liver disease
    Bedossa, Pierre
    [J]. LIVER INTERNATIONAL, 2017, 37 : 85 - 89
  • [42] Non-alcoholic fatty liver disease in children
    Chaturvedi, Kanupriya
    Vohra, Pankaj
    [J]. INDIAN PEDIATRICS, 2012, 49 (09) : 757 - 758
  • [43] Mitochondria in non-alcoholic fatty liver disease
    Prip-Buus, C.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2016, 46 : 53 - 53
  • [44] Hyperuricemia in non-alcoholic fatty liver disease
    Dogru, T.
    Genc, H.
    Tapan, S.
    Bagci, S.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 1042 - 1043
  • [45] Non-alcoholic fatty liver disease and diabetes
    Reyes-Garcia, Rebeca
    Rozas-Moreno, Pedro
    Julio Llamoza-Torres, Camilo
    Mezquita-Raya, Pedro
    [J]. MEDICINA CLINICA, 2017, 148 (01): : 33 - 38
  • [46] CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Cocciolillo, Sila
    Parruti, Giustino
    Marzio, Leonardo
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 496 - 503
  • [47] Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV
    Verna, Elizabeth C.
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (03): : 211 - 223
  • [48] Lipidomics in non-alcoholic fatty liver disease
    Sofia Kartsoli
    Christina E Kostara
    Vasilis Tsimihodimos
    Eleni T Bairaktari
    Dimitrios K Christodoulou
    [J]. World Journal of Hepatology, 2020, 12 (08) : 436 - 450
  • [49] Non-alcoholic fatty liver disease in a toddler
    Fishbein, M
    Cox, S
    [J]. CLINICAL PEDIATRICS, 2004, 43 (05) : 483 - 485
  • [50] Genetics of non-alcoholic fatty liver disease
    Smyk, Wiktor
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 : 139 - 139